Novo Nordisk shares dive after heart medicine fails trial, dealing another blow toits pipeline

CNBCJuly 31, 2026 at 12:47 PM

The experimental medicine ziltivekimab didn't translate into a statistically meaningful reduction in major cardiovascular adverse events, Novo said Friday.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

Hargreave Hale AIM VCT allots 915,780 shares under DRIS

Investing.comJuly 31, 2026 at 12:40 PM

markets

Saba Capital, 10% owner, sells $4.6m in BlackRock ECAT shares

Investing.comJuly 31, 2026 at 12:45 PM

markets

If Social Security’s funding crisis is the elephant in the room, this is the mouse everyone has overlooked. You have been warned.

MarketWatchJuly 31, 2026 at 9:35 AM

← Back to all articles

Related Articles

Hargreave Hale AIM VCT allots 915,780 shares under DRIS

Saba Capital, 10% owner, sells $4.6m in BlackRock ECAT shares

If Social Security’s funding crisis is the elephant in the room, this is the mouse everyone has overlooked. You have been warned.